Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - IMMUNE DESIGN CORP. | ex312.htm |
| EX-32.2 - EXHIBIT 32.2 - IMMUNE DESIGN CORP. | ex322.htm |
| EX-31.1 - EXHIBIT 31.1 - IMMUNE DESIGN CORP. | ex311.htm |
| EX-32.1 - EXHIBIT 32.1 - IMMUNE DESIGN CORP. | ex321.htm |
| EX-10.20 - EXHIBIT 10.20 - IMMUNE DESIGN CORP. | ex1020.htm |
| EXCEL - IDEA: XBRL DOCUMENT - IMMUNE DESIGN CORP. | Financial_Report.xls |
| 10-K - 10-K - IMMUNE DESIGN CORP. | imdz-form10xk2014.htm |
| EX-10.19 - EXHIBIT 10.19 - IMMUNE DESIGN CORP. | ex1019.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-197748) pertaining to the Immune Design Corp. 2008 Equity Incentive Plan, Immune Design Corp. 2014 Omnibus Incentive Plan and Immune Design Corp. 2014 Employee Stock Purchase Plan of our report dated March 31, 2015, with respect to the financial statements of Immune Design Corp. included in this Annual Report (Form 10-K) for the year ended December 31, 2014.
/s/ Ernst & Young LLP
Seattle, Washington
March 31, 2015